Aquestive Therapeutics appoints new CLO/ CCO; Braender steps down as CLO

Aquestive Therapeutics, Inc.

Lori Braender steps down as CLO and CCO effective April 2, 2026; remains Corporate Secretary.
Thomas Zalewski appointed CLO and CCO effective April 2, 2026; former Partner at Day Pitney.
Zalewski receives inducement grant of 100k RSUs and 75k options, vesting over 3 years.
Braender eligible for severance payments and accelerated vesting under separation agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.